Facioscapulohumeral muscular dystrophy (FSHD) is the third most frequent inherited myopathy. We previously demonstrated that mesoangioblasts can be efficiently isolated from FSHD muscles, although their differentiation ability into skeletal muscle was variably impaired. This correlates with overall disease severity and degree of histopathologic abnormalities, since mesoangioblasts from morphologically normal muscles did not show any myogenic differentiation block. The aim of our present study was to verify whether mesoangioblasts from differentially affected FSHD muscles reproduce in vivo the same differentiation ability shown in vitro by studying their capability to form new muscle fibers during muscle regeneration of experimentally damaged muscles. We show that a diverse ability of FSHD mesoangioblasts to engraft and differentiate into skeletal muscle of SCID mice is strictly related to the characteristics of the muscle of origin, closely replicating in vivo what was previously observed in vitro. Moreover, we demonstrate that mesoangioblasts obtained from severely affected muscles scarcely integrate into muscle fibers, remaining mainly localized in the connective tissue. This suggests a defective migration in response to chemoattractants released by damaged fibers, as indicated by cell migration assays in response to HMGB1 and very low levels of RAGE expression, along with a decreased ability to fuse or to appropriately trigger the myogenic program. Our study indicates that FSHD mesoangioblasts from unaffected muscles can be used as selective treatment to halt muscle degeneration in severely affected muscles, and suggests that pharmacological and molecular interventions aimed to ameliorate homing and engraftment of transplanted autologous mesoangioblasts may open the way to cell therapy for FSHD patients, without requiring immunosuppression or genetic correction in vitro.
INTRODUCTION
leads to inappropriate upregulation of one or more candidate genes whose overexpression specifically affects skeletal muscle (23). Among these, the double homeo-Facioscapulohumeral muscular dystrophy (FSHD, OMIM #158900) is the third most frequent form of in-box chromosome 4 (DUX4) overlaps the last repeat unit and the adjacent sequence. Recently, the presence of herited muscle disease, following Duchenne muscular dystrophy (DMD) and myotonic dystrophy. In FSHD a specific single nucleotide polymorphisms (SNPs) in the chromosomal region distal to the last D4Z4 repeat has high variability is observed with regard to age at onset, severity and pattern of muscle involvement, both be-been demonstrated. This produces a canonical polyadenylation signal for transcripts derived from DUX4 that tween and within families, and the rate of disease progression appears unpredictable in a single affected indi-improves its stability. These observations suggest that a toxic gain of function ascribable to the stabilized distal vidual (11, 16) . FSHD is a dominant disease linked to contractions of a long stretch of 3.3 kb KpnI repeat units DUX4 transcript might play a pivotal role in FSHD pathogenesis (8) . (D4Z4) on the long arm of chromosome 4 (region 4q35). D4Z4 contains a transcriptional silencer whose deletion Despite the identification of the genetic defect associ-ated with FSHD, the molecular and cellular pathologic selective treatment aimed to ameliorate the function of severely affected muscles. effects of this deletion remain largely unknown. This makes, at the moment, impractical to envisage a specific MATERIALS AND METHODS gene therapy to correct the deleterious consequence on Patients skeletal muscle and improve muscle function.
In FSHD patients it is quite common to observe the Muscle biopsies were performed after written incoexistence of affected and apparently normal muscles.
formed consent at the Neuroscience Department of Catho-Myogenic autologous stem cells, expanded in vitro from lic University. We used fresh and fresh-frozen muscles apparently normal muscles and capable to engraft into obtained from seven patients with genetically confirmed damaged muscles, enhancing their regenerative activity, diagnosis of FSHD (age 30-67 years, mean 45 ± 16.5) could be used for therapeutic applications, repairing, at (Table 1) , one dermatomyositis (DM, age 33 years), and least in part, the degenerating muscles (9) . one normal control (CT, age 51 years). In our FSHD Previous studies conducted in animal models have patients the size of the pathogenic EcoRI fragment shown that transplanted myoblasts from phenotypically ranged between 20 and 33 kb, indicating the presence of unaffected FSHD muscles participate to localized musat least 3 KpnI repeats. No patients had infantile onset cle regeneration (25) . However, because of poor migraor carried very short fragments of 10-13 kb associated tory capacity of these muscle progenitors that are unable with the most severe phenotypes. Muscle biopsy was to cross vessel walls, myoblast-based cell therapy protoperformed on deltoid (FSHD1 and FSHD2) or quadricols require multiple intramuscular injections and may ceps (FSHD3, FSHD4, FSHD5, FSHD6, and FSHD7) target only individual muscles, posing technical chalmuscles. In each patient the overall clinical severity was lenges to develop new strategies to improve the graft assessed using the clinical severity scale (CSS) (19) , assuccess (2, 3) . signing a score ≤2 when the disease involved only facial In our previous study, we examined primary muscle and scapular muscles and a score of 3 (mildly affected), cells derived from FSHD muscles and showed that all 3.5 (moderately affected), and 4 to 5 (severely affected) FSHD myoblast cultures displayed several abnormalities when pelvic and lower limb muscles were involved. including decreased proliferation and clonogenic abili-Magnetic resonance imaging (MRI) study was perties and reduced life span. By contrast, the differentiaformed using a 1.5 Tesla scanner. Axial images were tion ability of FSHD myoblasts was preserved (15) . The obtained from shoulder girdle muscles and from psoas studies on FSHD myoblasts are relevant in view of the to distal foot muscles, along with coronal slices of the possible alternative use of myogenic stem cells localized lumbar and pelvic muscles. To assess whether the biopin the perivascular niche of muscle tissue, called messied muscle was affected and to evaluate the severity of oangioblasts, which are able to restore muscle morpholits involvement, we used clinical (manual evaluation of ogy and function in animal models of muscular dystromuscle strength and functional tests), muscle imaging phy when injected intra-arterially (20, 21) . This feature (areas of fatty fibrous substitution on T1-W images, fomakes mesoangioblasts an ideal candidate for a muscle cal areas of signal hyperintensity on T2-STIR sequences reconstitution therapy via cell transplantation. Indeed, suggesting presence of inflammatory infiltrates or edema), apparently unaffected FSHD muscles are a valuable and histopathologic criteria (increased variability of fisource of mesoangioblasts that can be isolated and exbers size, muscle fibers with internal nuclei, presence tensively grown in culture and induced to differentiate of degenerating and/or necrotic fibers, and inflammatory into myotubes. Mesoangioblasts may be easily isolated infiltrates) (15) . This research was approved by the Ethialso from affected muscles although their myogenic difcal Committee of our institution. ferentiation ability is variably but significantly impaired, Cell and Organ Cultures whereas proliferation rate and life span do not differ from normal controls (15) .
Tissue fragments of approximately 2 mm 3 including intramuscular vessels and surrounding mesenchymal tis-In the present study we show that human FSHD mesoangioblasts, obtained from differently affected muscles sue were plated and explants were cultured in Megacell-DMEM medium (Sigma, St. Louis, MO) with 5% se-and transplanted into the muscle of severe combined immune deficient (SCID) mice, have a variable ability to rum, and a cocktail of growth factors for a period of time ranging between 10 and 21 days. Tissues were di-integrate and differentiate into skeletal muscle in vivo with an efficiency that is strictly related to the character-gested with 0.1% trypsin and mechanically dissociated with 20-gauge needle. Cell suspension was plated in istics of the muscle of origin. Since mesoangioblasts offer the great advantage of possible systemic delivery, complete medium on gelatin-coated dishes. From the first passage on, cells were characterized by a triangular, our findings may open the way to future studies utilizing cells from unaffected muscles of FSHD patients for a adherent refractive shape and by a floating/loosely ad-herent round component. Since most of the cells were To determine whether human FSHD mesoangioblasts obtained from muscles with a different degree of impair-either poorly adherent or floating, for three passages we collected them by gently pipetting, thus eliminating ment recapitulated in vivo the behavior displayed in vitro, we selected four representative patients, in particu-most of the fibroblast and myoblast contamination (6, 14) . Cells were maintained in culture for several pas-lar FSHD1 and FSHD2 whose biopsies presented significant myopathic changes, and FSHD3 and FSHD4 sages. At every passage, cells were counted and viability was determined by trypan blue exclusion. For growth whose muscle biopsies did not show any histopathologic abnormality. Cells from FSHD patients were trans-curves, exponentially growing cells were seeded at appropriate concentrations to prevent confluence during planted into the tibialis anterior (TA) of four SCID mice (females, aged 8 weeks) (Charles River, Wilmington, the duration of the experiment. Viable cells were counted after 24, 48, and 72 h to determine the amount of MA) and their ability to participate in muscle regeneration was evaluated in parallel. Two control mice were cell proliferation.
transplanted with mesoangioblasts from one DM patient Characterization of Human Mesoangioblasts From and one normal control. The experiment was carried out FSHD by Fluorescence Activated Cell Sorting (FACS) in duplicate for each set of cells, and was performed two times. To avoid the experimental variability due to Phenotypic characterization of all mesoangioblasts cultures was performed by examining the expression of individual animals, we transplanted cells from "affected" and "unaffected" muscles on the posterior limbs the surface markers previously identified for human mesoangioblasts (6,14). Cells (5 × 10 4 ) were incubated (left and right, respectively) of the same mouse. Mesoangioblasts (1 × 10 6 ), all at passage 12, were trans-with fluoroscein isothiocyanate (FITC)-, phycoerythrin (PE)-, or phycoerythrin covalently linked to Cy5 (PC5)-planted by multiple injections performed into each TA (right and left) of six mice (two per group) (in two ex-conjugated monoclonal antibodies (mAbs) against AC133/ 1 (clone CD133/1), CD34, CD56 (Miltenyi Biotec, Au-periments, total mice number n = 12). Mice were anesthetized with an intraperitoneal injection of 10 ml/kg sa-burn, CA), vascular endothelial growth factor receptor II (VEGF-RII; KDR, R&D Systems, Minneapolis, MN), line solution containing ketamine (5 mg/ml) and xylazine (1 mg/ml). To induce muscle regeneration be-CD45, CD49b, CD44 (R3-242; all from Becton Dickinson, San Jose, CA), CD13 (Beckman, Fullerton, CA), fore each injection, focal muscle damage was induced by liquid nitrogen. In detail, after opening the fascia, anti-human fibroblasts (Gene Tex, Inc., Irvine, CA). Unlabeled samples and samples incubated with irrelevant TA muscles of each mouse were exposed to a severe cryodamage immediately before cell implantation. The isotype-matched fluorochrome-conjugated mAbs served as controls for background fluorescence. Cells were ana-injury consisted of two cycles of freezing-thawing by direct application for 5 s of a 1.5 × 2 mm metal probe, lyzed using Coulter Epics XL flow cytometer (Beckman Coulter Instrumentation Laboratory, Brea, CA).
precooled with liquid nitrogen, on the muscle surface at midway between the tendons. Freezing-thawing of the Skeletal Muscle Differentiation muscle was repeated two times to induce more severe of FSHD Mesoangioblasts muscle damage. Immediately after thawing, each muscle was injected with four aliquots of 25 × 10 4 cells each, Human mesoangioblasts differentiate down the skeletal muscle pathway under a variety of conditions, with both on the proximal and distal half of the cryodamaged muscle. In each treated animal, the extent of the induced the highest efficiency when exposed to medium conditioned by normal human myoblasts (14). Mesoangi-muscle damage showing regenerative changes was assessed by morphological evaluation of sections serial to oblasts were cultured in conditioned medium for 4 days and then exposed for 7 days to differentiation medium those used for lamin A/C and spectrin immunohistochemistry stained by H&E, alkaline phosphatase, and containing 1% bovine serum albumin (BSA) (without serum). Fusion index was expressed as number of myo-developmental myosin heavy chain immunofluorescence. nuclei/number of total nuclei, visualized by Hoechst Analysis and Quantification of Cell 33258 staining (Molecular Probes Inc., Eugene, OR).
Implantation In Vivo Intramuscular Transplantation of FSHD
Mice were sacrificed 2 months after the transplant.
Mesoangioblasts Into SCID Mice
The entire TA muscles were excised and snap-frozen into liquid nitrogen-cooled isopentane. Cryostat sections All the experimental activities involving vertebrate animals were approved by our Institutional Review were taken throughout the whole muscle, from tendon to tendon, in order to analyze human cells distribution. Board and conducted in the Animal Care Facilities of the Catholic University strictly meeting the animal care
The presence of human cells in the host muscle was evaluated by immunolabeling of the human proteins regulations (D. L.116 issued on January 27, 1992).
lamin A/C and spectrin on 8-µm-thick serial sections stained with May Grunwald-Giemsa and counted in 20 randomly selected microscopic fields per membrane. using species-specific antibodies. In all experimental samples, transverse sections taken at 80-µm intervals Assays were performed in triplicate and the experiment was repeated twice. along a longitudinal dimension of about 800 µm between both ends of the TA muscle were initially analyzed and all contained human cells. Within this muscle Western Blot Analysis segment containing implanted cells, four representative Tissues were homogenized and protein extracts were sections were selected at regular intervals to count the obtained according to standard methods. Cells were harnumber of human nuclei either located outside or inside vested and homogenized in lysis buffer. Thirty micromuscle fibers. For each selected section nuclei were grams were of protein was separated by SDS-PAGE and counted in three different microscopic fields at 40× blotted onto nitrocellulose membranes (Schleicher& magnification. Efficiency of muscle regeneration was Schuell, Relliehausen, Germany). Blots were incubated calculated as previously described (24) as the ratio bewith one of the following antibodies: monoclonal antitween the number of human nuclei within spectrin-posiskeletal myosin fast (1:500, MY-32, Sigma), monotive muscle fibers and the total number of human nuclei clonal anti-myogenin (1:100, FD-5, Santa Cruz Biotech-(NIF = number of human nuclei inside fibers/total numnology, Santa Cruz, CA), polyclonal anti-HMGB1 (1: ber of human nuclei). 500, Becton Dickinson Biosciences Pharmingen), monoclonal anti-receptor for advanced glycation end products Immunochemistry (RAGE, 1:500, Chemicon, Temecula, CA), polyclonal This was performed on unfixed 8-µm-thick cryostat anti-pIκBα (1:1000, Cell Signaling Technology, Bevsections. For immunocytochemistry, cells were cultured erly, MA), monoclonal anti-β-actin (1:2500, Sigma). on gelatin-coated optical quality plastic m-Dishes (ibidi After incubation with the appropriate HRP-conjugated Integrated Biodiagnostics, Munich, Germany) and fixed secondary antibody, immunocomplexes were visualized in 4% paraformaldehyde for 15 min. The following priby enhanced chemiluminescence (Amersham Healthmary antibodies were used: monoclonal anti-skeletal care, Piscataway, NJ) and quantified by densitometry. myosin fast (1:100, MY-32, Sigma), monoclonal antihuman specific lamin A/C (1:200) and monoclonal anti-Reverse Transcriptase-Polymerase spectrin (1:50) (Novocastra, Newcastle Upon Tyne, Chain Reaction (RT-PCR) UK), monoclonal anti-myosin heavy chain develop-Total RNA was extracted from all the samples using mental type (1:20, MHCd, Novocastra), polyclonal anti-Trizol (Invitrogen), according to the manufacturer's inhigh mobility group box 1 protein (HMGB1, 1:100, Bestructions. Total RNA (2 µg) was used as template for cton Dickinson). Detection of immunocomplexes was first-strand cDNA synthesis using Superscript II and performed using the appropriate secondary Alexa Fluor random hexamers as primers (Invitrogen). The cDNAs 488 or 594 conjugated antibody (Invitrogen, Carlsbad, were amplified for RAGE and β-actin using the follow-CA). Hoechst 33258 staining (Molecular Probes Inc., ing primers: RAGE, forward 5′-CACACTGCAGTCG Eugene, OR.) was used to visualize cell nuclei. Samples GAGCTAA-3′ and reverse 5′-GCTACTGCTCCACCT were analyzed using a TCS SP5 laser scanning confocal TCTGG-3′; β-actin, forward 5′-TACATGGCTGGGGT microscope (Leica Microsystems, Wetzlar, Germany).
GTTGAA-3′ and reverse 5′-AAGAGAGGCATCCTC ACCCT-3′. PCR conditions for RAGE were: 30 cycles Chemotaxis Assay with annealing temperature of 55°C and 1.5 mM MgCl 2 . Cell migration assays were performed using transwell Primers for RAGE and β-actin amplified a fragment of permeable supports with 24-mm well (Corning, Lowell, 191 and 217 bp, respectively. PCR conditions for each MA). Polycarbonate membranes (8-µm pores) were set of primers yielded amplification in the linear range. coated with 1% type A porcine skin gelatin (Sigma).
The PCR products were electrophoresed on 2% agarose gel. Either serum-free MegaCell-DMEM medium (Sigma) (negative control), medium containing 5% serum (posi-Statistical Analysis tive control), or medium containing 100 ng/ml HMGB1 (HMG Biotech, Milan, Italy) were placed into the lower Data are reported as means ± SD. Statistical analysis was performed in all experiments by ANOVA for re-chamber. Then 1 × 10 5 mesoangioblasts/well, resuspended in 2.3 ml medium, were placed in the upper peated measures and comparisons between groups were assessed by Student's t-test. Adjustment for multiple chamber and incubated overnight at 37°C in 5% CO 2 . After incubation nonmigrating cells remaining on the comparisons was made, when necessary, by the use of the Bonferroni correction method; values of p ≤ 0.05 upper surface of the filters were mechanically detached, and cells that had migrated to the lower surface were were considered statistically significant. 
RESULTS

Patients
In this study we included seven FSHD patients different in terms of severity of clinical involvement and size of the EcoRI fragment. Two patients received a biopsy on the deltoid muscle that is frequently spared or only mildly affected in FSHD. Indeed, in these patients clinical evaluation showed a mild to moderate hypotrophy of this muscle that was associated with moderate myopathic changes on histopathology (FSHD1 and FSHD2). Out of the five patients who underwent a biopsy on quadriceps, in two patients (FSHD3, FSHD4) this muscle was unaffected on clinical and MRI examination (not shown) and showed no histopathologic abnormalities. In the other three cases (FSHD5, FSHD6, FSHD7), the quadriceps resulted unequivocally affected by both clinical and MRI evaluation, with different degrees of histopathologic involvement ( Table 1) . 
Mesoangioblast Isolation From FSHD Muscle Biopsies
ficiency (14,15). However, a possible effect of age on mesoangioblasts differentiation that is peculiar of FSHD Mesoangioblasts were isolated as previously decannot be completely excluded and remains to be further scribed (6, 14) . From the first passage on, cells were investigated. Mesoangioblasts obtained from the morcharacterized by the typical morphology of human mesphologically abnormal muscles of the more severely afoangioblasts (6,14), with triangular adherent and floatfected patients (FSHD1, FSHD2, and FSHD6, with ing/loosely adherent rounded cells. Since most of the moderate/severe myopathic changes) were able to fuse cells were poorly adherent, they were passed three times only into spare myosin-positive myotubes (fusion index by gentle pipetting, thus reducing fibroblast and my-0.14 ± 0.13). Moreover, these myotubes were short and oblast contaminations. Cells were kept in culture up to most of them contained no more than two nuclei. Mes-22 population doublings, when large flat cells undergooangioblasts from FSHD5 and FSHD7, presenting mild ing senescence started to appear. There was no differmyopathic changes, gave rise to a higher percentage of ence in life span, number, and morphology of cells isocells able to fuse into myosin-positive thin and mainly lated from affected or apparently normal muscles ( Fig. binucleated myotubes (fusion index 0.28 ± 0.06). 1A, left column). Notably, the proliferation rate of all On the contrary, mesoangioblasts from the apparently FSHD mesoangioblasts was comparable and indepenspared quadriceps of FSHD3 and FSHD4 differentiated dent from the severity of the disease and patients' age into multinucleated myosin-positive myotubes (fusion (Fig. 1B) . Doubling time from all FSHD cultures was index 0.7 ± 0.08), with no significant difference from 30.13 ± 3.35 h and did not differ significantly from what normal control mesoangioblasts (Fig. 1A, right column, previously observed (15) . There were no differences in Table 1 ). the amount and phenotypic characteristics of cells iso-Of note, myoblasts isolated from the same FSHD bilated from fresh or fresh-frozen muscles. The phenoopsies were able to fully differentiate into multinucletypic characterization was performed by analyzing exated myotubes, regardless of impairment of the muscle pression of the surface markers recently identified for of origin. human mesoangioblasts (6,14). Cells from all patients, analyzed at various passages, were homogeneously Intramuscular Transplantation of FSHD strongly positive for CD44 (96.6 ± 3.2%) and CD13
Mesoangioblasts Into SCID Mice (96.77 ± 3.02%), positive for CD49b (82.86 ± 6.6%),
To determine whether human FSHD mesoangioblasts and negative for CD34, CD133, and CD45 (not shown).
obtained from muscles with a different degree of impair-In particular, only a small fraction of all FSHD cultures ment also keep their different myogenic potency in vivo, was positive for CD56 and human fibroblast surface anwe transplanted them into the TA of SCID mice and tigen (5.2 ± 2.8% and 1.48 ± 0.28%, respectively), indievaluated their ability to participate to muscle regeneracating a negligible contamination of our cultures by mytion. No significant differences between treated animals oblasts and fibroblasts. This was independent from the were observed regarding the extent of linear and transmuscle of origin.
versal area of damaged muscle where regeneration was In addition, all FSHD mesoangioblasts were positive induced, as assessed by morphological evaluation of for ALP (95 ± 4.21%), a marker identifying human adult sections stained by H&E, alkaline phosphatase, and demesoangioblasts as the in vitro progeny of pericytes velopmental myosin heavy chain immunofluorescence (6,14).
(not shown) that were serial to those used for immuno-FSHD Mesoangioblast Differentiation histochemistry.
Into Skeletal Muscle
Transplantation success was assessed by histological identification of human antigens within murine muscle Human mesoangioblasts differentiate into skeletal muscle under a variety of conditions, with the highest tissue. In particular, we analyzed the nuclear envelope marker lamin A/C, to track the fate of human cells, and efficiency when exposed to human normal myoblastconditioned medium (14). As recently described by our spectrin that shows a true fusion event between donor cells and recipient fibers. Comparable numbers of hu-group, despite their normal characteristics, FSHD mesoangioblasts differentiate into skeletal muscle to a dif-man lamin A/C-positive cells were found in all transplanted muscles, spread in a longitudinal dimension of ferent extent, in clear correlation with the overall disease severity and degree of involvement of the muscle of ori-approximately 800 ± 80 µm and transversally distributed throughout the entire muscle belly on a given section gin (as evaluated by clinical, MRI, and histopathological examination). This differentiation defect did not corre- (Table 2 ). However, cells from affected FSHD muscles were consistently located mainly in the endomysial and late with patients' age since, in our hands, mesoangioblasts from aged controls, DM, and polymyositis fully perymisial connective tissue rather than integrated within regenerating fibers. This may reflect a defect in local differentiate into multinucleated myotubes with high ef- spectrin ( Fig. 2A, B) cells mainly localized in the muscle interstitium, with only few nuclei located beneath the basal lamina of spectrin-positive fibers. Furthermore, the number of corresponding control medium was significantly higher (p = 0.04) compared to those from affected muscle, in-spectrin-positive fibers was significantly higher in muscles transplanted with mesoangioblasts from unaffected dicating a reduced sensitivity to HMGB1 (Fig. 3 ). Since HMGB1 signaling is mainly mediated by RAGE, we in-muscles compared to mesoangioblasts from affected ones (p ≤ 0.05) ( Fig. 2A-C) . vestigated the expression of this receptor and found low levels of RAGE both at mRNA and protein levels in No significant difference in terms of number of human nuclei (Fig. 2B) and number of spectrin-positive mesoangioblasts obtained from affected muscles (Fig.  4A, B) . The lower expression of RAGE does not appear fibers was observed among muscles transplanted with FSHD mesoangioblasts from unaffected muscles versus to simply reflect a corresponding lower expression of the ligand cytokine in the muscle of origin, since by DM and normal control cells (Fig. 2C) .
Western blot on muscle biopsy homogenates, severely
Chemotaxis Assay and HMGB1-RAGE Expression
affected muscles showed a higher expression of HMGB1 compared to apparently normal muscles (Fig. 4C) . In in FSHD Mesoangioblasts fact, also by immunocytochemistry on frozen muscle sections, clinically and pathologically affected FSHD HMGB1, a nuclear DNA-binding protein that interacts with a variety of transcription factors, is secreted in muscles displayed, in addition to nuclear HMGB1, increased cytoplasmic and extracellular immunoreactivity the extracellular milieu by inflammatory cells, acts as a cytokine, and can also be passively released by necrotic (likely due to acetylated HMGB1 for the most part) (4), that is correlated to the presence of endomysial inflamma-or damaged cells thus promoting inflammation (1, 5, 26) . This protein is a powerful chemoattractant for muscle tory mononuclear infiltrates and necrotic fibers (Fig. 4D ).
Nuclear factor kappa light chain enhancer of acti-progenitor cells such as murine mesoangioblasts in vitro and in vivo (7, 10, 17, 18) . Because mesoangioblasts ob-vated B cells (NF-κB) activation is required for mesoangioblasts migration in response to the tissue-damage sig-tained from severely affected muscles remained mainly localized within perymisial-endomysial connective tis-naling molecule HMGB1. The phosphorylation of the NF-κB inhibitor IκBα at Ser32 and Ser36 by inhibitory sue, possibly reflecting a defect in local migration, we investigated the migration ability in vitro of all mesoan-κβ kinase (IκKβ), leads to its polyubiquitination and proteasomal destruction. This induces the nuclear trans-gioblasts used, by comparing their transmigration across a septum of a Boyden apparatus in response to HMGB1 location of NF-κB p50/p65 and p50/c-Rel heterodimers and the transcription of target genes. Because HMGB1 (7). Similar transwell assays have been already used as a reliable indicator of the mechanisms controlling cellular induces activation of the canonical pathway of NF-κB via phosphorylation of endogenous IκBα, we examined trafficking in vivo (13,18). A remarkable difference in migration ability in response to HMGB1 (100 ng/ml) pIκBα expression in mesoangioblasts from FSHD muscles with a different degree of impairment. Interestingly, was observed between cells from apparently normal and affected muscles (p = 0.01). Interestingly, only for cells mesoangioblasts obtained from unaffected muscles constitutively expressed higher levels of pIκBα compared obtained from unaffected muscle, the number of migrating mesoangioblasts in response to HMGB1 versus the to affected ones (Fig. 5A, B ). Figure 2 . In vivo myogenicity of FSHD mesoangioblasts was tested by intramuscular transplantation in severe combined immune deficient (SCID) mice. (A) After transplants, the two TAs of the same mouse injected with FSHD mesoangioblasts from affected and apparently normal muscles showed a different ability of these stem cells to integrate and participate to muscle regeneration. In particular, in the tibialis anterior (TA) muscle transplanted with cells from affected muscles (FSHD1 and FSHD2) a large number of human nuclei (lamin A/C positive labeled in green) were localized mainly in the connective tissue, with only few human nuclei located beneath the basal lamina of spare spectrin-positive fibers (labeled in red, inset). In the muscle transplanted with mesoangioblasts from apparently normal muscles (FSHD3 and FSHD4) numerous fibers express human spectrin and contain human lamin A/C-positive myonuclei. The inset shows one spectrin-positive muscle fiber containing three human nuclei. The lower photomicrographs shows at higher magnification that the vast majority of transplanted human cells from apparently normal muscles (FSHD3 and FSHD4) have originated muscle fibers expressing human spectrin and that only rare human nuclei are located in the endomysium outside muscle fibers. Hoechst staining was used to identify both human and murine nuclei (blue). Scale bars: 100 µm in the higher four panels, 25 µm in the insets, 50 µm in the lower panels. (B) By quantitative evaluation the efficiency in muscle regeneration was significantly higher in muscles transplanted with FSHD3 and FSHD4 mesoangioblasts compared to those receiving FSHD1 and FSHD2 cells (p ≤ 0.05). NIF: number of human nuclei inside fibers/total number of human nuclei. (C) Quantitative evaluation of spectrin-positive fibers, in relation to the total number of human nuclei, showed a significant difference between muscles transplanted with FSHD3 and FSHD4 mesoangioblasts compared to those receiving FSHD1 and FSHD2 cells (p ≤ 0.05). 
FACING PAGE
DISCUSSION
autologous myogenic stem cells capable to engraft within damaged muscles enhancing their regenerative capacity. In the present study we have analyzed human FSHD mesoangioblasts obtained from muscles with a different
The reason of the selective sparing of several muscles in FSHD in spite of the same genetic abnormality, simi-degree of impairment and demonstrated that their ability to integrate and differentiate into skeletal muscle in vivo lar to what is observed in other inherited muscle diseases such as hereditary inclusion-body myopathy or oculo-is variable and strictly related to the characteristics of the muscle of origin, thus recapitulating in vivo the be-pharyngeal muscular dystrophy, remains elusive. However, this observation has brought up the possibility to havior displayed in vitro.
Molecular pathogenesis of FSHD has been unveiled take advantage of muscles relatively spared by the pathologic process as a source of myogenic stem cells for several aspects; however, mechanisms leading to progressive muscle degeneration are yet unidentified.
that could be used in cell therapy protocols in FSHD patients. With the goal to halt the disease progression and limit muscle damage, it is reasonable to use in vitro expanded
Mesoangioblasts have demonstrated a significant, though partial, capability to restore damaged muscles gree of histopathologic alterations of the muscle of origin. By contrast, all primary muscle satellite cells de-when delivered intra-arterially (20, 21) . In fact, they possess the ability to colonize injured muscles by crossing rived from unaffected and affected FSHD muscles are always able to differentiate into multinucleated myo-the endothelium, mostly skipping the capillary filters of the body such as liver and lungs.
tubes, although they have impaired proliferation and clonogenic abilities and display, in some cases, abnormal In a previous work we demonstrated that FSHD mesoangioblasts from apparently normal muscles can be morphology. This suggests that the two starting populations of myogenic stem cells are clearly distinct and may easily isolated, extensively grown in culture, and induced to differentiate into myotubes that apparently do behave differently even when exposed to identical differentiating culture conditions. not display the morphological abnormalities observed in primary myoblast cultures obtained from the same mus-
The aim of our present study was to verify whether mesoangioblasts expanded from differentially affected cles (15) . Conversely, the myogenic differentiation ability of mesoangioblasts from affected muscles is variably FSHD muscles reproduce in vivo the same differentiation ability shown in vitro by investigating their capabil-but significantly impaired, with a differentiation defect correlating with the overall disease severity and the de-ity to form new muscle fibers during muscle regenera-tion of experimentally damaged muscles. Although the sized. Several chemoattractants generated in dystrophic muscles are known to favor the homing of circulating intra-arterial delivery represents the more natural and effective way to target mesoangioblasts into damaged progenitors to damaged tissues. In particular, extracellular HMGB1 and RAGE are a ligand/receptor pair suffi-muscles, intramuscular transplantation avoids the introduction of additional variables that may interfere with cient for mesoangioblasts homing in vivo (18) . Accordingly, here we have demonstrated a significant difference quantification of FSHD transplanted cells, such as variable crossing of the endothelial barrier and systemic mi-in migration ability in response to HMGB1 in vitro between cells from normal and affected FSHD muscles. gration with loss of cells skipping the capillary filter. In order to inject simultaneously in each animal mesoangi-Moreover, similarly to what previously described in other dystrophic muscles (18), HMGB1 expression was oblasts from two different patients we used intramuscular transplantation, hence eliminating most of the vari-higher in severely affected FSHD muscles compared to apparently normal ones. Nevertheless, mesoangioblasts ability related to individual animals. This approach allowed us also to comparatively examine mesoangioblasts with isolated from severely affected muscles exhibited lower levels of the HMGB1 receptor, RAGE, in comparison to a different behavior in vitro after transplantation in the same muscle microenvironment. Mesoangioblasts from mesoangioblasts from unaffected muscles. Since HMGB1 signals prevalently through RAGE, our data strongly apparently normal muscles were able to integrate and efficiently participate to muscle regeneration, giving rise suggest a possible dysregulation of this signaling pathway that might account for the impaired ability of these to a significantly high number of human spectrin-positive fibers. By contrast, mesoangioblasts obtained from cells to respond to extracellular HMGB1 and engraft within damaged muscle. However, we cannot exclude impaired muscles remained mainly localized in the muscle interstitium. These data confirm the differentiation the existence of a different unidentified chemoattractor/ receptor complex that FSHD muscles might use to at-defect of FSHD mesoangioblasts from affected muscles observed in vitro and demonstrate that the ability to tract mesoangioblasts. Our findings are in agreement with a previous study form fully differentiated myotubes in vitro predicts their in vivo behavior. Moreover, the differentiation defect showing an activation of RAGE-NF-κB pathway induced by oxidative stress in unaffected FSHD muscles exhibited by FSHD mesoangioblasts seems an intrinsic property of these cells and is not dependent on the local that express high levels of RAGE and hydrogen peroxide (12). An increased production of advanced glycation environment, since FSHD mesoangioblasts always behave in the same manner (both in vivo and in vitro) in end products (AGEs) due to elevated reactive oxygen species (ROS) levels has been provided as a possible relation only to the characteristics of the muscle of origin. In addition, the fact that all the mesoangioblast sets explanation for the high expression levels of RAGE in apparently normal FSHD muscles. Moreover, abnormal from both apparently unaffected and affected muscles contained comparable low contaminating amounts of ligation of AGEs to RAGE is known to cause further ROS production and RAGE stimulation and elevated myoblasts and fibroblasts rules out the possibility that the results obtained simply reflect the presence of other level of hydrogen peroxide may in turn induce NF-κB activation. The reason why RAGE is constitutively less types of cells.
Yet unknown putative environmental cues, related to expressed in cultured mesoangioblasts from affected muscles remains to be clarified. the specific molecular defect of the disease and likely more active in the advanced stage of myopathy, may NF-κB activation is required for mesoangioblasts migration in response to several chemoattractants released operate in the pathological muscle milieu and determine the block of skeletal muscle differentiation of mesoangi-in damaged muscles, such as HMGB1. The phosphorylation of the NF-κB inhibitor IκBα leads to its polyubi-oblasts from muscles with evident pathologic abnormalities. On the contrary, mesoangioblasts from clinically quitination and proteasomal degradation and induces the nuclear translocation of NF-κB and the transcription of and pathologically spared FSHD muscles keep a normal myogenic ability. Indeed, their regenerative capacity is target genes. In the present study, we observed that even in the absence of any stimulation, mesoangioblasts from comparable to that of mesoangioblasts obtained from DM muscle, which are by far more efficient than normal apparently normal FSHD muscles express higher levels of pIκBα reflecting NF-κB activation. The degree of mesoangioblasts as they have, in our experience, the highest myogenicity (14). Since mesoangioblasts from NF-κB activation in mesoangioblasts from affected and apparently normal muscles may correlate with a variable affected muscles remained mainly localized in the connective tissue with only few human nuclei integrated receptiveness to migration stimuli present in the host regenerative skeletal muscle environment necessary for a within spare spectrin-positive fibers, the existence of a possible migration defect, in addition to the demonstrated successful engraftment. Our data show that migration ability of FSHD mes-differentiation impairment in culture, can be hypothe-
